HOME > PUBLICATIONS > Arthritis & Rheumatism > 1998 > SUBJECT > Subject Index - G

Subject Index - G

Back to Subject Index | Return to Arthritis & Rheumatism Table of Contents Page

  • Galanin, in fibromyalgic muscle tissue, 1689
  • Gallbladder ischemic necrosis, in catastrophic antiphospholipid syndrome, 1318
  • Gastrointestinal system
    • misoprostol and, 16
    • upper intestinal manometry, in SSc, 1874
  • Gelatin/chondroitin 6-sulfate microspheres, for joint therapy, 2185
  • Genes. See also Alleles; entries beginning with 'HLA'; Polymorphisms
    • in camptodactyly-arthropathy-coxa vara-pericarditis syndrome, 730
    • control of collagen-induced arthritis in T cell receptor β-chain transgenic mice, 256
    • expanded B1a cells in NZM2410 lupus-prone mice and, 1652
    • α1(I) procollagen gene expression in SSc, 2048
    • new non-MHC locus and collagen-induced arthritis, 2122
    • in OA inheritance, 1064, 1227
    • prevalence of SSc in Choctaw and, 1725, 1729
    • in RA, identification in synoviocytes, 1356
    • in RA in Pima Indians, 1464
    • in SLE, in African-origin populations, 2091
    • in SLE, polymorphic CYP17, 940
    • in SLE, associated with promoter polymorphisms of mannose-binding lectin, 1663
    • in SLE susceptibility, 596, 1714
    • versus socioeconomic factors in SLE susceptibility, 1161, 1173
    • Tax protein activation of synovial cells and, 1995
  • Giant cell (temporal) arteritis (GCA)
    • cardiovascular risk factors and, 1960
    • inflammatory response in, 26
    • MRI and, 1702
    • multiple myeloma-associated amyloidosis and, 1312
    • platelet-derived growth factor, intimal hyperplasia, and ischemia in, 623
    • prevalence in United States, 778
    • role of anticardiolipin antibodies in, 701
    • visual loss and cerebrovascular accidents in, 1497
  • Glomerulonephritis, 2-CdA in the treatment of SLE-associated, 335, 1704
  • Glucocorticoids
    • apoptosis in SLE and, 823
    • joint tissue metabolism in early RA and, 1203
    • in rheumatic diseases, hypothesis of actions of, 761
  • Glycoproteins
    • β2-glycoprotein I, and human anticardiolipin IgG, 1026, 1513
    • β2-glycoprotein I in SLE, 215
    • β2-glycoprotein I-dependent antiphospholipid autoantibodies, endothelial cells and, 1738
  • Glycosaminoglycans, biosynthesis, in human articular cartilage, 157
  • Gonarthritis, NO and interleukin-1 in, 634
  • Gout
    • historical concept of, 1511
    • interleukin-8 receptor binding chemokines in, 900
    • prevalence in United States, 778
    • pseudogout following intraarticular injection of sodium hyaluronate, 939
    • pseudogout in carpal tunnel syndrome, 182
  • Graft-versus-host disease, human cytomegalovirus associated with, 10
  • Granulocyte-macrophage colony-stimulating factor (GM-CSF), in antiphospholipid syndrome, 224
  • Growth factors
    • articular cartilage, 1331
    • in giant cell (temporal) arteritis, platelet-derived growth factor, intimal hyperplasia, and ischemia, 623
    • human cytomegalovirus associated with transforming growth factor β1, 10
    • in OA, insulin-like growth factor 1, 891
    • in RA, cytokine modulation of vascular endothelial growth factor, 1258
    • in RA, platelet-derived growth factor monoclonal expansion of synoviocytes, 1979
    • in RA, insulin-like growth factor binding protein 5, identification in synoviocytes, 1356
    • transforming growth factor β1, COMP synthesis induced by, 997
    • transforming growth factor β1 (TGFβ1), and monoclonal expansion of synoviocytes in RA, 1979
    • zymosan-induced gonarthritis, NO and interleukin-1, 634
  • Growth-related oncogene α (GROα), and interleukin-8 receptor binding chemokines in gout, 900
  • Guinea pig models, collagenase expression in, 877